MAPT and Alzheimer disease: Notably, proteins such as CD44, GFAP, and MAPT- previously recognized as significantly upregulated proteins in AD human brain tissues using proteomics analysis and are considered as potential biomarkers for AD [73, 74]- were among the upregulated DEPs, suggesting AD organoids align with the established AD characteristics.